Tamarack Advisers’s HCA Healthcare HCA Stock Holding History

Tamarack Advisers’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,000	Closed	-$845K	–	30
2017 Q4	$845K	Sell	1,000 -121	-11%	-$9.72K	0.46%	26
2017 Q3	$454K	Buy	+1,121	New	+$90.2K	0.28%	25

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tamarack Advisers's HCA Position: Q2 2021 in Review

Tamarack Advisers sold out of HCA Healthcare (HCA) in Q2 2021, closing a stake of 30,000 shares — an estimated $5.65M sold.

Tamarack Advisers first reported a position in HCA in Q1 2017 and held it in 3 quarters. The position peaked at $7.12M in Q1 2017. 824 funds tracked by Wall St. Rank hold HCA as of Q2 2021.

Tamarack Advisers reported no remaining HCA Healthcare position as of Q2 2021 after selling out during the quarter.
Tamarack Advisers sold 30,000 HCA Healthcare shares in Q2 2021, an estimated $5.65M.
Tamarack Advisers first reported a position in HCA Healthcare in Q1 2017 and held it in 3 quarters.
Tamarack Advisers's HCA Healthcare position peaked at $7.12M in Q1 2017.
824 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2021.

Based on Tamarack Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.